144 related articles for article (PubMed ID: 38644244)
21. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
van der Valk MJM; Hilling DE; Bastiaannet E; Meershoek-Klein Kranenbarg E; Beets GL; Figueiredo NL; Habr-Gama A; Perez RO; Renehan AG; van de Velde CJH;
Lancet; 2018 Jun; 391(10139):2537-2545. PubMed ID: 29976470
[TBL] [Abstract][Full Text] [Related]
22. Is the Management of Rectal Cancer Using a Watch and Wait Approach Feasible, Safe and Effective in a Publicly Funded General Hospital?
Kaul S; Rao C; Mane R; Tan KL; Khan AHA; Hussain MS; Shafi MA; Buettner F; Banerjee S; Boulton R; Bhargava A; Huang J; Hanson M; Raouf S; Ball S; Rajendran N
Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e25-e34. PubMed ID: 34454807
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
[No Abstract] [Full Text] [Related]
24. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
25. [Role of radiotherapy in watch and wait strategy after neoadjuvant trerapy for rectal cancer].
Wang YQ; Zhang Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):252-257. PubMed ID: 32192304
[TBL] [Abstract][Full Text] [Related]
26. Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
Temmink SJD; Peeters KCMJ; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Melenhorst J; Burger JWA; Wolthuis A; Renehan AG; Figueiredo NL; Pares O; Martling A; Perez RO; Beets GL; van de Velde CJH; Nilsson PJ;
Br J Surg; 2023 May; 110(6):676-684. PubMed ID: 36972213
[TBL] [Abstract][Full Text] [Related]
27. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting management decisions in rectal cancer in clinical practice: results from a national survey.
Habr-Gama A; Perez RO; São Julião GP; Proscurshim I; Nahas SC; Gama-Rodrigues J
Tech Coloproctol; 2011 Mar; 15(1):45-51. PubMed ID: 21057971
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
[TBL] [Abstract][Full Text] [Related]
30. A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.
Weiser MR; Chou JF; Kim JK; Widmar M; Wei IH; Pappou EP; Smith JJ; Nash GM; Paty PB; Cercek A; Saltz LB; Romesser PB; Crane CH; Garcia-Aguilar J; Schrag D; Gönen M
JAMA Netw Open; 2022 Sep; 5(9):e2233859. PubMed ID: 36173634
[TBL] [Abstract][Full Text] [Related]
31. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis.
Tan S; Gao Q; Cui Y; Ou Y; Huang S; Feng W
Int J Colorectal Dis; 2023 Oct; 38(1):246. PubMed ID: 37787779
[TBL] [Abstract][Full Text] [Related]
32. Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?
Fernandez LM; Figueiredo NL; Habr-Gama A; São Julião GP; Vieira P; Vailati BB; Nasir I; Parés O; Santiago I; Castillo-Martin M; Carvalho C; Parvaiz A; Perez RO
Dis Colon Rectum; 2020 Aug; 63(8):1053-1062. PubMed ID: 32692070
[TBL] [Abstract][Full Text] [Related]
33. Watch and Wait for rectal cancer in inflammatory bowel disease.
Azevedo JGM; Fernandez L; Herrando AI; Santiago I; Pares O; Parvaiz A
BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37429643
[TBL] [Abstract][Full Text] [Related]
34. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
Dossa F; Chesney TR; Acuna SA; Baxter NN
Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372
[TBL] [Abstract][Full Text] [Related]
35. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.
Habr-Gama A; Gama-Rodrigues J; São Julião GP; Proscurshim I; Sabbagh C; Lynn PB; Perez RO
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):822-8. PubMed ID: 24495589
[TBL] [Abstract][Full Text] [Related]
36. Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years.
Bahadoer RR; Peeters KCMJ; Beets GL; Figueiredo NL; Bastiaannet E; Vahrmeijer A; Temmink SJD; Meershoek-Klein Kranenbarg WME; Roodvoets AGH; Habr-Gama A; Perez RO; van de Velde CJH; Hilling DE;
Br J Surg; 2021 Dec; 109(1):114-120. PubMed ID: 34738104
[TBL] [Abstract][Full Text] [Related]
37. The Role of Probe-Based Confocal Laser Endomicroscopy (pCLE) in the Diagnosis of Sustained Clinical Complete Response Under Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Adenocarcinoma: a Score Validation.
Safatle-Ribeiro AV; Ribeiro U; Lata J; Baba ER; Lenz L; da Costa Martins B; Kawaguti F; Moura RN; Pennacchi C; Gusmon C; de Lima MS; de Paulo GA; Nahas CS; Marques CF; Imperiale AR; Cotti GC; Maluf-Filho F; Nahas SC
J Gastrointest Surg; 2023 Sep; 27(9):1903-1912. PubMed ID: 37291428
[TBL] [Abstract][Full Text] [Related]
38. [Short-course radiotherapy combined with CAPOX and PD-1 inhibitor for the total neoadjuvant therapy of locally advanced rectal cancer: the preliminary single-center findings of a prospective, multicentre, randomized phase II trial (TORCH)].
Wang YQ; Shen LJ; Wan JF; Zhang H; Wang Y; Wu X; Wang JW; Wang RJ; Sun YQ; Tong T; Huang D; Wang L; Sheng WQ; Zhang X; Cai GX; Xu Y; Cai SJ; Zhang Z; Xia F
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):448-458. PubMed ID: 37217353
[No Abstract] [Full Text] [Related]
39. A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol.
Vatandoust S; Wattchow D; Sposato L; Michael MZ; Leung J; Gormly K; Chen G; Symonds EL; Tie J; Papanicolas LE; Woods S; Gebski V; Mead K; Kuruni A; Karapetis CS
BMC Cancer; 2022 Mar; 22(1):222. PubMed ID: 35232427
[TBL] [Abstract][Full Text] [Related]
40. Low rectal cancer treatment strategies: a cohort study assessing watch and wait.
Pinto JC; Pereira AD; Pimenta A; Pedro C; Fernandez G; Marques I; Miguel I; Freire J; Maciel J; Venâncio J; D'Orey L; Mirones L; Limbert M; Labareda M; Chaves P; Fonseca R; Barroca R; Ferreira T; Marques T; Rosa I
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2631-2638. PubMed ID: 32435893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
